ArticleIndian journal of sexually transmitted diseases and AIDS
Dual burden of tuberculosis and human immunodeficiency virus: Outcomes and implications from Chittoor district, Andhra Pradesh.
Article in Indian journal of sexually transmitted diseases and AIDS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection remain a significant public health challenge, particularly in resource-limited settings. This study investigates the prevalence, clinical characteristics, and treatment outcome of TB-HIV coinfected patients in Chittoor, Andhra Pradesh, India. Methodology: A retrospective cross-sectional observational study was conducted using hospital records in an antiretroviral therapy (ART) Centre of a tertiary care hospital from October 2021 to September 2023. Among 3383 registered HIV patients, 129 (3.8%) were diagnosed with TB. Clinical data, diagnostic methods, and treatment outcomes were analyzed. Results: Most patients were males (62.0%), with a mean age of 39.7 years. Pulmonary TB was the most common type (93.0%), and 58.1% of cases were microbiologically confirmed. The median baseline and follow-up CD4 counts were 309 and 430 cells/mm Conclusion: Despite progress in ART coverage and TB diagnosis, challenges in treatment adherence and mortality reduction persist. Strengthening diagnostic infrastructure, adherence strategies, and integrated TB-HIV care is crucial to improve outcomes in co-infected populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.